1. Virucidal Activity of Garcinia parvifolia Leaf Extracts in Animal Cell Culture. Adnan, A., Z.N. Allaudin, H. Hani, H.S. Loh, T.J. Khoo, K.N. Ting, and R. Abdullah. BMC Complementary and Alternative Medicine, 2019. 19(1): p. 169. PMID[31291936]. PMCID[PMC6617885].
[PubMed]. HIV_07_2019.
2. 8-Anilinonaphthalene-L-sulfonic acid as a Potential Novel HIV-1 gp41 Fusion Inhibitor. Cano-Munoz, M., S. Jurado, A. Camara-Artigas, B. Morel, and F. Conejero-Lara. European Biophysics Journal with Biophysics Letters, 2019. 48: p. S84-S84. ISI[000473420400205].
[WOS]. HIV_07_2019.
3. Design, Synthesis and Biological Evaluation of 3-Hydroxyquinazoline-2,4(1H,3H)-diones as Dual Inhibitors of HIV-1 Reverse Transcriptase-associated RNase H and Integrase. Gao, P., X. Cheng, L. Sun, S. Song, M. Alvarez, J. Luczkowiak, C. Pannecouque, E. De Clercq, L. Menendez-Arias, P. Zhan, and X. Liu. Bioorganic & Medicinal Chemistry, 2019. 27(17): p. 3836-3845. PMID[31324562].
[PubMed]. HIV_07_2019.
4. DNA Quadruplex-based Inhibitor with Flexible Fragments at the 3' Terminal Shows Enhanced anti-HIV-1 Fusion Activity. Han, Z., Y. Tang, H. Ren, K. Liu, and L. Xu. Journal of Pharmaceutical Sciences, 2019. 108(7): p. 2243-2246. PMID[30797782].
[PubMed]. HIV_07_2019.
5. Potent anti-HIV Ingenane diterpenoids from Euphorbia ebracteolata. Huang, Y.S., Y. Lu, C.H. Chen, K.H. Lee, and D.F. Chen. Journal of Natural Products, 2019. 82(6): p. 1587-1592. PMID[31184480].
[PubMed]. HIV_07_2019.
6. Synthesis and Biological Evaluation of Dihydroquinazoline-2-amines as Potent Non-Nucleoside Reverse Transcriptase Inhibitors of Wild-type and Mutant HIV-1 Strains. Jin, K.J., Y.L. Sang, S. Han, E. De Clercq, C. Pannecouque, G. Meng, and F. Chen. European Journal of Medicinal Chemistry, 2019. 176: p. 11-20. PMID[31091477].
[PubMed]. HIV_07_2019.
7. Structural and Pharmacological Evaluation of a Novel Non-Nucleoside Reverse Transcriptase Inhibitor as a Promising Long Acting Nanoformulation for Treating HIV. Kudalkar, S.N., I. Ullah, N. Bertoletti, H.K. Mandl, J.A. Cisneros, J. Beloor, A.H. Chan, E. Quijano, W.M. Saltzman, W.L. Jorgensen, P. Kumar, and K.S. Anderson. Antiviral Research, 2019. 167: p. 110-116. PMID[31034849]. PMCID[PMC6554724].
[PubMed]. HIV_07_2019.
8. Design, Synthesis and in Vitro Evaluation of Novel anti-HIV 3-Pyrazol-3-yl-pyridin-2-one Analogs. Kumar, S., S. Gupta, S. Gaikwad, L.F. Abadi, L.K.K. Bhutani, S. Kulkarni, and I.P. Singh. Medicinal Chemistry, 2019. 15(5): p. 561-570. PMID[30398119].
[PubMed]. HIV_07_2019.
9. Synthesis, Spectral Characterization, Docking Studies and Antiviral Activity of Phosphorylated Derivatives of Lopinavir Intermediate. Kuruva, C.S., S.P. Gandavaram, T.B. Shaik, V. Chintha, N.R. Chamarthi, S.K. Ghosh, and R. Wudayagiri. ChemistrySelect, 2019. 4(20): p. 6101-6105. ISI[000473422500015].
[WOS]. HIV_07_2019.
10. Multifunctional Mesoporous Curcumin Encapsulated Iron-phenanthroline Nanocluster: A New anti-HIV Agent. Sharma, A., A. Yadav, N. Gupta, S. Sharma, R. Kakkar, K. Cwiklinski, E. Quaye, S.D. Mahajan, S.A. Schwartz, and R.K. Sharma. Colloids and Surfaces B-Biointerfaces, 2019. 180: p. 289-297. PMID[31071568].
[PubMed]. HIV_07_2019.
11. Novel Protease Inhibitors Containing C-5-Modified bis-Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2' Ligands That Exert Potent Antiviral Activity against Highly Multidrug-resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance. Takamatsu, Y., M. Aoki, H. Bulut, D. Das, M. Amano, V.R. Sheri, L.C. Kovari, H. Hayashi, N.S. Delino, A.K. Ghosh, and H. Mitsuya. Antimicrobial Agents & Chemotherapy, 2019. 63(8): e00372-00319. PMID[31085520].
[PubMed]. HIV_07_2019.
12. HIV-1 Reverse Transcriptase Inhibitory Activity of Flavones and Chlorogenic acid Derivatives from Moquiniastrum floribundum (Asteraceae). Tamayose, C.I., P.B. Torres, N. Roque, and M.J.P. Ferreira. South African Journal of Botany, 2019. 123: p. 142-146. ISI[000472017400017].
[WOS]. HIV_07_2019.
13. A 3D-QSAR Study of HIV-1 Integrase Inhibitors Using RASMS and Topomer CoMFA. Tong, J.B., S.S. Qin, S. Lei, and Y. Wang. Chinese Journal of Structural Chemistry, 2019. 38(6): p. 867-881. ISI[000471687800002].
[WOS]. HIV_07_2019.
Patent Citations
14. Deuterated Nucleoside Reverse Transcriptase Inhibitors. Alexandre, F.-R. and I. Raheem. Patent. 2019. 2018-16212163 20190185508: 35pp.
[Patent]. HIV_07_2019.
15. Preparation of Triazolophthalazine Compounds, Use as Human Immunodeficiency Virus Inhibitors of HIV Vif-Dependent Degradation of Apobec3. Ananthan, S., C.E. Augelli-Szafran, R.P. Bennett, H.C. Smith, and P.K.M. Venukadasula. Patent. 2019. 2018-US67609 2019133666: 227pp.
[Patent]. HIV_07_2019.
16. Substituted Heterocyclic-Pyridinones as HIV-1 Nef-Hck Kinase Inhibitors and Their Use in Treatment of HIV. Augelli-Szafran, C.E., O. Moukha-Chafiq, T.E. Smithgall, L.A. Emert-Sedlak, H. Shi, S. Tanner, and V. Pathak. Patent. 2019. 2018-US66920 2019126567: 150pp.
[Patent]. HIV_07_2019.
17. Preparation of Benzamide Compounds as Antitumor and anti-HIV Agents. Pinchman, J.R., P.Q. Huang, K.D. Bunker, R.K. Sit, and A.A. Samatar. Patent. 2019. 2019-US12699 2019139900: 239pp.
[Patent]. HIV_07_2019.